Organigram Global Inc. (OGI)

Nasdaq: OGI · Pharmaceutical Preparations · Toronto · filing with the SEC since 2015

Full chart Alerts Compare

Grade5.5

◀ Past 7.1● Present 5.5▶ Future 4.1

3 est.

Overview Business Financials Grade Forecast Sentiment Ownership People Filings Patents Chart

The grade of Organigram Global Inc.

Nine metrics read from its own filings, by tense

Headline grade

5.5/10

◀ Past7.130% of the headline

● Present5.540% of the headline

▶ Future4.130% of the headline

All three tenses have at least two readings, so the archetype blend applies as printed.

Of the nine metrics, 6 read as filed from the record and 3 are SI estimates, each with its reasoning, its confidence and what would change it on its card.

◀ Past

What did they actually do?

7.1/1030% of the headline grade · 2 of 3 filed, 1 estimated

Surviving crises

as filed

8.2/10

Has it survived what it has been through?

No warning events in its filings since 2017.

weight 33% of this tense · 82nd percentile among 497 sector filers · read for itself

From the record

Organigram Global Inc.'s filings since 2017 show no warning events in the scan: no bankruptcy or receivership notice, no debt default notice, no exchange listing notice, no restatement warning, no auditor change, no material cyber incident and no late-report notice (its current reports).

A production reading, recomputed from the filings on every data build, read from EDGAR Nov 13, 2026.

Track record

as filed

7.3/10

What has it actually done, year after year?

+52.2% a year over 6 filed years; profitable in 1 of 6.

weight 45% of this tense · 74th percentile among 323 sector filers · read for its customers

From the record

Organigram Global Inc.'s 6 filed years say what it did: revenue went from CAD 12 million in fiscal 2018 to CAD 160 million in fiscal 2024, up 52.2% a year; it rose in 4 of 5 years; the deepest fall was 9% from fiscal 2020 to fiscal 2021; net income was positive in 1 of 6 of those years (its annual reports).

What it rests on

revenue growth over the filed span52.2%top 23% of its family
the share of years revenue rosetop 25% of its family
the share of filed years with a profittop 30% of its family
the deepest fall from a revenue peak8.8%top 28% of its family

A production reading, recomputed from the filings on every data build, read from EDGAR Nov 13, 2026.

Shareholder treatment

SI estimate

4.9/10

How has it treated the people who own it?

SI estimate 4.9/10, confidence 35 of 100 (one part).

weight 22% of this tense · 49th percentile among 464 sector filers · read for its shareholders

SI estimate Inferred, not read as filed

Why it is an estimate: Read from one part only, the share count over the years, which ranks in the bottom 49% of 464 in its family; fewer than two of the parts can be read: the share count over the years, and the cash returned against a positive operating cash flow or net income.
What the record cannot read: Fewer than two of the parts can be read: the share count over the years, and the cash returned against a positive operating cash flow or net income.
How it was reasoned: one part: the share count over the years, the one part on file, ranked among 464 in its family.
Confidence: 35 of 100
What would change it: A filing that carries the missing parts replaces this estimate with the filed reading.

From the record

SI estimate, not a filed reading: Organigram Global Inc.'s shareholder treatment is put at 4.9 of 10 with a confidence of 35 of 100, because read from one part only, the share count over the years, which ranks in the bottom 49% of 464 in its family; fewer than two of the parts can be read: the share count over the years, and the cash returned against a positive operating cash flow or net income. A filing that carries the missing parts replaces this estimate with the filed reading.

● Present

What are they doing right now?

5.5/1040% of the headline grade · 1 of 3 filed, 2 estimated

Financial health

SI estimate

5.1/10

Is it financially healthy right now?

SI estimate 5.1/10, confidence 20 of 100 (family median).

weight 45% of this tense · 50th percentile among 480 sector filers · read for itself

SI estimate Inferred, not read as filed

Why it is an estimate: The newest annual statements on file are more than two years old, so the desk assumes the typical reading of its industry family, the median of 480 members with one.
What the record cannot read: The newest annual statements on file are more than two years old.
How it was reasoned: family median, 480 readings behind it.
Confidence: 20 of 100
What would change it: Its next annual report on file with the inputs replaces this estimate with the filed reading.

From the record

SI estimate, not a filed reading: Organigram Global Inc.'s financial health is put at 5.1 of 10 with a confidence of 20 of 100, because the newest annual statements on file are more than two years old, so the desk assumes the typical reading of its industry family, the median of 480 members with one. Its next annual report on file with the inputs replaces this estimate with the filed reading.

Industry position

as filed

6.3/10

How strong is its position in its industry?

top 37% of 315 in its family; net margin -28.4%.

weight 33% of this tense · 63rd percentile among 315 sector filers · read for its customers

From the record

Organigram Global Inc.'s standing among 315 graded names in its industry family: revenue of CAD 160 million in fiscal 2024 is not ranked by size, since the family reports in another currency; a net margin of -28.4% ranks in the top 34%; revenue growth of 16.1% a year over the last 3 filed years ranks in the top 41% (its annual reports).

What it rests on

net margin-28.4%top 34% of its family
three-year revenue growth16.1%top 41% of its family

A production reading, recomputed from the filings on every data build, read from EDGAR Nov 13, 2026.

Leadership

SI estimate

5.0/10

What are the people in charge doing?

SI estimate 5.0/10, confidence 20 of 100 (family median).

weight 22% of this tense · 50th percentile among 371 sector filers · read for its shareholders

SI estimate Inferred, not read as filed

Why it is an estimate: It files no Form 8-K (a foreign issuer reports on Form 6-K), so officer and director changes cannot be read there; no officer or director has filed a Form 3, 4 or 5 for it in the last fifteen months, so the years in charge cannot be read, so the desk assumes the typical reading of its industry family, the median of 371 members with one.
What the record cannot read: It files no Form 8-K (a foreign issuer reports on Form 6-K), so officer and director changes cannot be read there; no officer or director has filed a Form 3, 4 or 5 for it in the last fifteen months, so the years in charge cannot be read.
How it was reasoned: family median, 371 readings behind it.
Confidence: 20 of 100
What would change it: Its next annual report on file with the inputs replaces this estimate with the filed reading.

From the record

SI estimate, not a filed reading: Organigram Global Inc.'s leadership is put at 5.0 of 10 with a confidence of 20 of 100, because it files no Form 8-K (a foreign issuer reports on Form 6-K), so officer and director changes cannot be read there; no officer or director has filed a Form 3, 4 or 5 for it in the last fifteen months, so the years in charge cannot be read, so the desk assumes the typical reading of its industry family, the median of 371 members with one. Its next annual report on file with the inputs replaces this estimate with the filed reading.

▶ Future

What are they set up to do next?

4.1/1030% of the headline grade · 3 of 3 filed

Room to expand

as filed

3.1/10

How much room does it have to grow?

bottom 31% of 273 in its family for room to expand.

weight 45% of this tense · 31st percentile among 273 sector filers · read for itself

From the record

Organigram Global Inc.'s room to grow, from the newest filed statements (fiscal 2024): cash from operations less capital spending is -0.5% of revenue (top 30%); a gross margin of 29.7% (bottom 14%); research spending of 7% of revenue (bottom 9%) (its annual report).

What it rests on

cash from operations less capital spending against revenue-0.5%top 30% of its family
gross margin29.7%bottom 14% of its family
research spending against revenue7.0%bottom 9% of its family

A production reading, recomputed from the filings on every data build, read from EDGAR Nov 13, 2026.

Growth drivers

as filed

4.5/10

What could actually drive growth from here?

bottom 45% of 306 in its family for growth drivers.

weight 33% of this tense · 45th percentile among 306 sector filers · read for its customers

From the record

Organigram Global Inc.'s growth drivers, from the filed years to fiscal 2024: revenue grew 16.1% a year over the last three filed years against 52.2% over all 6, slowing (bottom 16% of its family); the newest year grew 4.5% (bottom 45%); research spending grew 70.5% a year (top 5%); capital spending grew -49.5% a year (bottom 22%) (its annual reports). Organigram Global Inc. tags no split of its revenue by line in the annual report on file, so growth by line cannot be read here; research and capital spending are on the trend.

What it rests on

three-year growth against the whole span-36.0 points a yearbottom 16% of its family
the newest year's revenue growth4.5%bottom 45% of its family
three-year growth of research spending70.5%top 5% of its family
three-year growth of capital spending-49.5%bottom 22% of its family

A production reading, recomputed from the filings on every data build, read from EDGAR Nov 13, 2026.

Expectations vs reality

as filed

5.7/10

Did its newest year beat what its own record pointed to?

top 43% of 233 in its family for expectations against reality.

weight 22% of this tense · 57th percentile among 233 sector filers · read for its shareholders

From the record

Organigram Global Inc.'s newest year against its own record: revenue of CAD 160 million in fiscal 2024 came in 15.4% below the CAD 189 million its prior three years' pace pointed to (bottom 34% of its family); net income of CAD 45 million against a prior three-year average of CAD 94 million (top 31%); a net margin of -28.4% against losses larger than its revenue before (top 33%) (its annual reports).

What it rests on

revenue against the prior three years' pace-15.4%bottom 34% of its family
net income against the prior three years' average+52%top 31% of its family
net margin against its prior average+82.2 pointstop 33% of its family

A production reading, recomputed from the filings on every data build, read from EDGAR Nov 13, 2026.

The grade is the company against its own industry, from its filings. It is not a view on the share price. How the grade is made

SI Assistanton OGI · research, not advice